The biological pathways of Alzheimer disease: A review
M Calabrò, C Rinaldi, G Santoro… - AIMS …, 2020 - pmc.ncbi.nlm.nih.gov
Alzheimer disease is a progressive neurodegenerative disorder, mainly affecting older
people, which severely impairs patients' quality of life. In the recent years, the number of …
people, which severely impairs patients' quality of life. In the recent years, the number of …
Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches
Abstract Alzheimer's disease (AD), the most common progressive neurodegenerative
disorder is characterized by the formation of extracellular amyloid plaques and intracellular …
disorder is characterized by the formation of extracellular amyloid plaques and intracellular …
Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer's disease: the role, regulation and restoration of LRP1
A Ramanathan, AR Nelson, AP Sagare… - Frontiers in aging …, 2015 - frontiersin.org
Amyloid beta (Aβ) homeostasis in the brain is governed by its production and clearance
mechanisms. An imbalance in this homeostasis results in pathological accumulations of …
mechanisms. An imbalance in this homeostasis results in pathological accumulations of …
Mendelian randomization study updates the effect of 25-hydroxyvitamin D levels on the risk of multiple sclerosis
R Wang - Journal of translational medicine, 2022 - Springer
Background Observational studies and previous Mendelian randomization (MR) studies
have shown that genetically low 25-hydroxyvitamin D (25OHD) levels are associated with a …
have shown that genetically low 25-hydroxyvitamin D (25OHD) levels are associated with a …
Genetics of Alzheimer's disease
V Chouraki, S Seshadri - Advances in genetics, 2014 - Elsevier
Alzheimer's disease (AD) represents the main form of dementia, and is a major public health
problem. Despite intensive research efforts, current treatments have only marginal …
problem. Despite intensive research efforts, current treatments have only marginal …
Mendelian randomization study on the causal effects of omega-3 fatty acids on rheumatoid arthritis
G Zhu, S Zhou, Y Xu, R Gao, H Li, B Zhai, X Liu… - Clinical …, 2022 - Springer
Objectives To resolve the ongoing debate on the role of plasma omega-3 fatty acids in
rheumatoid arthritis (RA), we attempted to identify the association between omega-3 intake …
rheumatoid arthritis (RA), we attempted to identify the association between omega-3 intake …
Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier
Background PICALM is one of the most significant susceptibility factors for Alzheimer's
disease (AD). In humans and mice, PICALM is highly expressed in brain endothelium …
disease (AD). In humans and mice, PICALM is highly expressed in brain endothelium …
The role of PICALM in Alzheimer's disease
W Xu, L Tan, JT Yu - Molecular neurobiology, 2015 - Springer
Alzheimer's disease (AD) is a highly heritable disease (with heritability up to 76%) with a
complex genetic profile of susceptibility, among which large genome-wide association …
complex genetic profile of susceptibility, among which large genome-wide association …
Osteoarthritis and risk of type 2 diabetes: a two‐sample Mendelian randomization analysis
Background Physical inactivity is an independent risk factor for type 2 diabetes (T2D).
Osteoarthritis (OA) is a common joint disease that limits patients' physical activity, which may …
Osteoarthritis (OA) is a common joint disease that limits patients' physical activity, which may …
Mendelian randomization study on causal association of IL-6 signaling with pulmonary arterial hypertension
M Zhang, Q Zeng, S Zhou, G Zhu, Y Xu… - Clinical and …, 2023 - Taylor & Francis
Background A recent Mendelian randomization (MR) did not support an effect of the lead
interleukin-6 receptor (IL-6 R) variant on risk of pulmonary arterial hypertension (PAH). Thus …
interleukin-6 receptor (IL-6 R) variant on risk of pulmonary arterial hypertension (PAH). Thus …